Matches in Nanopublications for { <http://purl.org/np/RA446hNvw07wY-Ua_dtulJSrQD6kH7PZXaQb-b-Qw9YlI#association> ?p ?o ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "Of relevance, lisdexamfetamine dimesylate, a psy- chostimulant approved for the treatment of ADHD, has been recently assessed and approved for the treat- ment of moderate to severe binge eating disorder in adults.5,6 In a phase 2 efficacy and safety trial, pa- tients with binge eating disorder who were prescribed doses of 50 and 70 mg/day doses of lisdexamfetamine demonstrated reduced binge eating days per week, greater binge eating cessation rates, and greater rates of clinical global improvement at 11 weeks compared with the placebo control group" assertion.
- association subject DB01255 assertion.
- association predicate treats assertion.
- association object MONDO_0005452 assertion.
- association has_population_context cohort assertion.
- association relation OffLabelIndication assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association publications 28125174 assertion.
- association provided_by NeuroDKG assertion.